Patents-Review.com
🔗 Permalink
Assignee profile:

EPIONTIS GMBH

City:

BERLIN

Country:

Germany

Published Applications:

16

Last publication date:

2019-07-11

Patent Grants:

15

Last grant date:

2020-09-22

Top Inventors for applications by EPIONTIS GMBH

These are the the leading inventors for applications assigned to EPIONTIS GMBH:

Recent patent applications by EPIONTIS GMBH

EPIONTIS GMBH based in BERLIN, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2019-07-11 ✅ Patent 10,781,492 granted on 2020-09-22
US20190211403A1
Chemistry; metallurgy

Epigenetic method for the identification of subpopulations of CD8+ T lymphocytes, in particular CD8 alpha and beta T lymphocytes

 #2 | 2018-10-11 ✅ Patent 10,894,984 granted on 2021-01-19
US20180291447A1
Chemistry; metallurgy

Method for identifying the quantitative cellular composition in a biological sample

 #3 | 2018-08-02 ✅ Patent 11,643,687 granted on 2023-05-09
US20180216185A1
Chemistry; metallurgy

LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells

 #4 | 2018-08-02 ✅ Patent 11,761,041 granted on 2023-09-19
US20180216184A1
Chemistry; metallurgy

PARK2 as epigenetic marker for the identification of immune cells, in particular monocytes

 #5 | 2017-11-16 ✅ Patent 10,590,475 granted on 2020-03-17
US20170327871A1
Chemistry; metallurgy

Detection of immune cells, in particular T cells through DNA-methylation analysis of the genes CCR6 and BLR1

 #6 | 2016-01-28 ✅ Patent 10,208,346 granted on 2019-02-19
US20160024578A1
Chemistry; metallurgy

Method for identifying the quantitative cellular composition in a biological sample

 #7 | 2015-10-29 ✅ Patent 10,273,545 granted on 2019-04-30
US20150307946A1
Chemistry; metallurgy

Epigenetic method for the identification of subpopulations of CD8+ T lymphocytes, in particular CD8 alpha and beta T lymphocytes

 #8 | 2015-01-01 ✅ Patent 9,926,599 granted on 2018-03-27
US20150004602A1
Chemistry; metallurgy

Epigenetic marker for the identification of CD3CD4 positive T lymphocytes

 #9 | 2014-08-21 ✅ Patent 10,294,527 granted on 2019-05-21
US20140234837A1
Chemistry; metallurgy

Epigenetic marker for the identification of natural killer cells

 #10 | 2014-08-14 ✅ Patent 9,556,484 granted on 2017-01-31
US20140227703A1
Chemistry; metallurgy

Epigenetic marker for the identification of IL17 positive T cells in complex samples

 #11 | 2013-10-03
US20130260378A1
Chemistry; metallurgy

METHOD FOR DETERMINING CANCER PATIENT SURVIVAL BASED ON ANALYZING TUMORINFILTRATING OVERALL T-LYMPHOCYTES

 #12 | 2013-04-11 ✅ Patent 9,783,846 granted on 2017-10-10
US20130089861A1
Chemistry; metallurgy

Detection of immune cells, in particular T cells through DNA-methylation analysis of the genes and

#13 | 2013-01-03 ✅ Patent 9,840,736 granted on 2017-12-12
US20130005600A1
Chemistry; metallurgy

Epigenetic marker for the identification of T lymphocytes

 #14 | 2012-04-19 ✅ Patent 9,096,900 granted on 2015-08-04
US20120094290A1
Chemistry; metallurgy

Epigenetic marker for the identification of natural killer cells

 #15 | 2009-12-10 ✅ Patent 8,298,762 granted on 2012-10-30
US20090305234A1
Chemistry; metallurgy

Specific DNAS for Epigenetic Characterisation of cells and tissues

 #16 | 2007-11-22 ✅ Patent 10,876,163 granted on 2020-12-29
US20070269823A1
Chemistry; metallurgy

Detection and quality control of regulatory T cells through DNA-methylation analysis of the Foxp3 gene

Also check out Epiontis GmbH's (Berlin, Germany) applicant profile with 9 patent applications submitted.

AssigneeID:

41316 ⎘